Scarica l'app Stockscreener
117.78
0.46%
-0.54
Dopo l'orario di chiusura:
117.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$118.32
Aprire:
$114.2
Volume 24 ore:
796.50K
Relative Volume:
0.98
Capitalizzazione di mercato:
$6.63B
Reddito:
$738.26M
Utile/perdita netta:
$48.89M
Rapporto P/E:
136.24
EPS:
0.8645
Flusso di cassa netto:
$91.69M
1 W Prestazione:
+2.94%
1M Prestazione:
-5.75%
6M Prestazione:
-18.90%
1 anno Prestazione:
-10.04%
Intervallo 1D:
$114.20
$121.72
Intervallo di 1 settimana:
$109.66
$121.72
Portata 52W:
$102.97
$175.77
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
117.78 | 6.63B | 738.26M | 48.89M | 91.69M | 0.8645 |
ISRG
Intuitive Surgical Inc
|
452.07 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.56 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.28 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.09 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | HSBC Securities | Buy |
| 2025-09-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen (NASDAQ: RGEN) details 2025 growth, CEO pay and governance in 2026 proxy - stocktitan.net
Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance Australia
Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Are Options Investors Anticipating Significant Movement in Repligen Shares? - Bitget
Are Options Traders Betting on a Big Move in Repligen Stock? - Zacks Investment Research
Will Repligen Corporation face regulatory challenges2026 Intraday Action & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart - capital.com
Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Repligen Corp Stock: Bioprocessing Leader with Strong Growth in Biopharma Supply Chain - AD HOC NEWS
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.38% on Mar 27 - GuruFocus
Vanguard amends Schedule 13G/A for Repligen (RGEN): reports 0 shares - Stock Titan
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound? - finance.yahoo.com
RGEN PE Ratio & Valuation, Is RGEN Overvalued - Intellectia AI
E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan
Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan
Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan
Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan
RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus
H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada
H.C. Wainwright raises Repligen stock price target on strong growth - Investing.com
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat
Is Repligen (NASDAQ:RGEN) Influenced By Nasdaq Index Volatility? - Kalkine Media
Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance
Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS
Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - ad-hoc-news.de
Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance
Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance
270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat
Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat
Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com
Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance
Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance
Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st
Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corporation to Present at Upcoming March Conferences - ChartMill
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Repligen Corporation $RGEN Shares Sold by TD Asset Management Inc - MarketBeat
NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan
Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan
Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):